Advertisement

Neuroscience and Behavioral Physiology

, Volume 42, Issue 8, pp 876–879 | Cite as

Genetic Risk Factors for Multiple Sclerosis in the Population of the Altai District

  • I. V. Smagina
  • S. A. Elchaninova
  • A. G. Zolovkina
  • Yu. N. Ignatova
  • E. A. Kudryavtseva
Article
  • 40 Downloads

A case-control study in the Russian population of the Altai District showed that increased risk of multiple sclerosis was associated with DR15 and DR3 and the combination of the female gender and the A allele of the rs1800629 TNFα gene. There was no association between the occurrence of this disease and polymorphism of the CD40 gene (rs60764022).

Keywords

multiple sclerosis DRB1 gene tumor necrosis factor alpha (TNFα) gene CD40 gene 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. N. Boiko and O. O. Favorova, “Multiple sclerosis: molecular and cellular mechanisms,” Mol. Biol., 29, No. 4, 727–749 (1995).Google Scholar
  2. 2.
    I. V. Smagina, Yu. N. Lichenko, A. S. Fedyanin, and S. A. Elchaninova, “Epidemiology of multiple sclerosis in the Altai district,” Nevrol. Zh., No. 1, 24–27 (2010).Google Scholar
  3. 3.
    O. O. Favorova, O. G. Kulakova, and A. N. Boiko, “Multiple sclerosis as a polygenic disease: the current state of this question,” Genetika, 46, No. 3, 302–313 (2010).PubMedGoogle Scholar
  4. 4.
    T. E. Shmidt and N. N. Yakhno, Multiple Sclerosis: Guidelines for Doctors [in Russian], MEDpress Inform, Moscow, 2nd Edition (2010).Google Scholar
  5. 5.
    E. N. Benveniste, V. T. Nguyen, and D. R. Wesemann, “Molecular regulation of CD40 gene expression in macrophages and microglia,” Brain Behav. Immun., 18, 7–12 (2004).PubMedCrossRefGoogle Scholar
  6. 6.
    R. Bomprezzi, P. E. Kovanen, and R. Martin, “New approaches to investigating heterogeneity in complex traits,” J. Med. Genet., 40, 553–559 (2003).PubMedCrossRefGoogle Scholar
  7. 7.
    J. Drulovic, D. Popadic, S. Mesaros, et al., “Decreased frequency of the tumor necrosis factor alpha –308 allele in Serbian patients with multiple sclerosis,” Eur. J. Neurol., 50, No. 1, 25–29 (2003).CrossRefGoogle Scholar
  8. 8.
    I. Duran et al., “Immunological profile of patients with primary progressive multiple sclerosis: expression of adhesion molecules,” Brain, 122, 2297–2307 (1999).PubMedCrossRefGoogle Scholar
  9. 9.
    O. O. Favorova, A. V. Favorov, A. N. Boiko, et al., “Three allele combinations associated with multiple sclerosis,” BMC Med. Genetics, 63, 1–9 (2006).Google Scholar
  10. 10.
    G. I. Forte, P. Ragonese, G. Salemi, et al., “Search for genetic factors associated with susceptibility to multiple sclerosis,” Ann. N.Y. Acad. Sci., 1067, 264–269 (2006).PubMedCrossRefGoogle Scholar
  11. 11.
    J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurol., 33, No. 12, 1444–1452 (1983).Google Scholar
  12. 12.
    G. Lucotte, C. Bathelier, and G. Mercier, “TNF-α polymorphisms in multiple sclerosis: no association with –238 and –308 promoter alleles, but the microsatellite allele aII is associated with the disease in French patients,” Multiple Sclerosis, 6, No. 2, 78–80 (2000).PubMedGoogle Scholar
  13. 13.
    G. Orozco, S. Eyre, A. Hinks, et al., “Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study,” Ann. Rheum. Dis., 69, 813–816 (2010).PubMedCrossRefGoogle Scholar
  14. 14.
    C. H. Polman, S. C. Reingold, C. Edan, et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald criteria,’” Ann. Neurol., 56, 840–864 (2005).CrossRefGoogle Scholar
  15. 15.
    S. Ristic et al., “Tumor necrosis factor-α-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients,” Eur. Neurol., 57, 203–207 (2007).PubMedCrossRefGoogle Scholar
  16. 16.
    K. Selmaj, C. Raine, B. Cannella, et al., “Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions,” J. Clin. Invest., 37, 949–954 (1997).Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • I. V. Smagina
    • 1
    • 2
  • S. A. Elchaninova
    • 3
  • A. G. Zolovkina
    • 3
  • Yu. N. Ignatova
    • 1
  • E. A. Kudryavtseva
    • 4
  1. 1.Department of Neurology, District Clinical HospitalBarnaulRussia
  2. 2.Department of Nervous Diseases with Neurology and Reflexotherapy, Faculty of Higher Qualification and Professional Specialist TrainingAltai State Medical UniversityBarnaulRussia
  3. 3.Department of Biochemistry and Clinical Laboratory DiagnosticsAltai State Medical UniversityBarnaulRussia
  4. 4.Novosibirsk State UniversityNovosibirskRussia

Personalised recommendations